OCC 1.16% 42.5¢ orthocell limited

Another great move and step forward towards the...

  1. 1,190 Posts.
    lightbulb Created with Sketch. 122
    Another great move and step forward towards the commercialisation of this product.
    As Bedger says the Aussie market and fund managers are tone deaf to the biotech sector.
    The needle will move with increasing sales and US FDA approvals - we will get there and the rewards will be significant.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.